← Latest Filings
K
Kumar Neil
Chief Executive Officer
Open-market buys
0
$0 total
Open-market sells
120
$61.5M total
Tracking since
Oct 2025
Activity timeline
Open-market sale — $89K
BridgeBio Pharma, Inc. · Sep 17, 2026
Open-market sale — $602K
BridgeBio Pharma, Inc. · Sep 17, 2026
Open-market trades from the last two years.
Holdings as last reported
3,568,447 Common Stock in BBIO
Held indirectly (By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.) · as of 2026-09-17
750,000 Common Stock in BBIO
Held indirectly (By NK 2026 GRAT) · as of 2026-09-17
Companies touched
BridgeBio Pharma, Inc.
CIK 0001743881
Maze Therapeutics, Inc.
CIK 0001842295